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Abstract
Background: A urinary tract infection (UTI) involves any part of the urinary system,
including the urethra, ureter, kidney, and bladder. Urinary tract infections are the most
common healthcare-associated infection reported to National Healthcare Safety
Network (NHSN). A UTI is also the second most frequent infection in long-term care
(LTAC) facilities, making it the most common cause of bacterial infection or sepsis and
hospitalization. Patients with urinary catheters are at an increased risk of infection, and
standard catheters reduce the body’s natural ability to cleanse the urinary tract of
microorganisms. Bacteria can colonize into biofilms that attach themselves to the
catheter surface and may cause catheter blockage and, as a result, develop a
resistance to antibiotics. Silver alloy-coated catheters can reduce biofilm formation and
colonization by releasing silver ions in the urinary tract.
Setting and Subjects: A long-term care facility for elderly patients ages 55 to 99 years
of age with frequent urinary tract infections due to chronic catheter use.
Aim: To determine the effect of silver alloy-coated urinary catheters in preventing
urinary tract infection compared with standard silicone or latex urinary catheters in
patients with chronic use.
Method: This quality improvement project used Kurt Lewin’s change model with the
PDSA method. The intervention involved the replacement of current standard urinary
catheters with silver-alloy coated urinary catheters for 5 weeks in a long-term care
facility.
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Result: A total of seven patients were initially enrolled in the quality improvement (QI)
project. Two dropped out due to worsening health-related issues. Forty percent had
negative urinalysis, another 40% were asymptomatic with multidrug-resistant bacteria,
and 20% had no negative urinalysis.
Conclusion: Using a silver alloy-coated urinary catheter reduced symptomatic catheterassociated urinary tract infection (CAUTI) occurrences as defined by clinical criteria.
Keywords: Catheter-associated urinary tract infection, asymptomatic bacteriuria,
silver alloy catheters, noble catheter, Foley catheter, urinary tract infection
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Introduction

Urinary tract infection (UTI) is among the most frequent healthcare-associated
infections globally. It is associated with increased mortality, prolonged hospitalization,
and increased healthcare costs. The main aim of this Quality Improvement Project is to
evaluate the efficacy of the silver alloy-coated catheter in preventing the incidence of
catheter-associated urinary tract infection (CAUTI) in patients with chronic catheter use.
CAUTI is often caused by multi-drug resistant strains that are globally detrimental to
human health.
According to the U.S. Centers for Disease Control and Prevention (CDC, 2022),
CAUTI is defined by positive urine culture (bacteriuria) and at least one of the following
symptoms: dysuria, fever, urinary urge or frequency, and costovertebral tenderness. It
occurs in 3-6 % of the time in catheterized patients
Magnusson et al. (2019) conducted a retrospective-prospective clinical case study
to investigate a case of a permanently (suprapubic) catheterized woman with
neurogenic bladder dysfunction due to frequent catheter-associated urinary tract
infection. In 2013, the patient's catheter was substituted for the silver alloy-coated
urinary catheter coated with a noble metal alloy (NMA) of gold, silver, and palladium.
The result showed that long-term use of an NMA-coated catheter was associated with
cessation of frequent CAUTIs in this patient, and no acute adverse effects about the
noble catheter were noted.
Likewise, according to Banaszak et al. (2020), The Infectious Disease Society of
America (IDSA) noted that acceptable guidelines for catheter use are substantial and
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symptomatic urinary retention in the face of ineffective medical therapy, urinary
incontinence for terminally ill patients, and correct monitoring of fluid status in critically ill
patients. Also, indwelling catheterization of the urinary bladder in SCI patients is an
independent risk factor for UTI development, with an estimated 50% of catheters placed
inappropriately and kept longer than necessary. Given that the highest incidence of
catheter-associated urinary tract infection (CAUTI) occurs in SCI patients, there is a
need for regular patient reassessment and discontinuation of the Foley catheter as soon
as possible in this high-risk population.
This quality improvement project evaluated the effectiveness of silver alloy-coated
urinary catheters in preventing recurrent urinary tract infection in chronic catheter use
like patients with neurogenic dysfunction, compared with current standard indwelling
catheters in a long-term care setting. A 10-day reflective practice was done in a longterm care facility to find the incidence of the frequency of CAUTI and the need for
practice change.
Problem Description
Catheter-associated urinary tract infections (CAUTIs) are a common
occurrence associated with increased patient morbidity and mortality. Any intervention
resulting in a decrease in the incidence of CAUTIs would have a significant impact on
patient quality of life and costs. Urinary tract infection is a severe complication in
patients with chronic bladder disfunction. Furthermore, Davenport & Keeley (2005)
asserts that despite improved treatment methods, urinary tract morbidity still ranks as
the second leading cause of death in SCI patient. Bladder catheterization is the most
crucial factor predisposing patients with neurogenic bladders to UTIs. By reviewing the
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current literature, the use of silver-alloy-coated hydrogel catheters can reduce CAUTIs
by 45% (Davenport & Keeley, 2005).
To identify the practice problem, patients 55 to 99 years old, both female and
male, with chronic catheter use due to bladder dysfunction, such as neurogenic bladder
post-spinal cord injuries, strokes, and multiple sclerosis, were followed for 10 days of
reflective practice. Seven patients were shown that met the criteria for silver alloycoated urinary catheter due to recurrent urinary tract infection and asymptomatic
bacteriuria due to bacteria colonization that needed antibiotic therapy with a positive
culture. These patients usually do not require antibiotic treatment because of not
meeting the criteria for treatment but must be treated due to liability purposes despite
education on antibiotic stewardship. Other diagnoses met during the reflective practice
review were pneumonia, hip and knee surgeries, and osteomyelitis due to a diabetic
wound. Another scenario is the non-UTI syndromes, whereby patients present with
nonspecific symptoms like confusion and lethargy. A urine dipstick will show positive
nitrite and leukocyte esterase and a colony count of 25-100 thousand with an identified
organism. This leads providers to prescribe antibiotics. Hence, the risk of inappropriate
antibiotic use in the scenarios above, i.e., asymptomatic bacteria and non-UTI
syndrome. This will in turn promote the emergence of multidrug-resistant organisms
(MDRO) and the increased risk of clostridium difficle infection adverse effects from
antibiotic medications. Ideas were generated via a search of literature review to assess
available knowledge and relevant studies showing the effectiveness of the use of these
noble alloy catheters in preventing frequent urinary tract infections, and given these
findings, the quality improvement study question was framed as follows:

QUALITY IMPROVEMENT PROJECT

7

P: In elderly patients ages 55-99, with chronic catheter use and recurrent urinary tract
infections (UTI)
I: Silver alloy-coated urinary catheter
C: Regular indwelling urinary catheter
O: Prevention of frequent urinary tract infection
T: 5 weeks
Project Framework
Kurt Lewin's change model can help bridge the gap between the old therapies
(antibiotics, increase risk catheters) in the treatment of frequent UTIs inherent in chronic
catheterization and alloy catheter use. Kurt Lewin’s change theory involves unfreezing,
change, and refreezing stages. This form of change model emphasizes that the process
of change entails creating the belief that a change is needed and moving forward to the
new desired level, and finally solidifying the new behavior and keeping it as the norm.
(Cummings et al., Bridgman, 2016).

This model was adopted to search for evidence-

based literature on background problems, interventions, and outcomes that support the
use of silver-coated urinary catheters in preventing CAUTIs. This model also supplies a
proper framework to organize and translate the evidence gathered into clinical practice.
Figure 1
Kurt Lewin’s Change Model (Cummings et al., 2016)
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New Intervention

Keep new intervention

Translation Method
This quality improvement project focused on preventing urinary tract infections in
patients with bladder dysfunction with frequent urinary tract infections due to chronic
use of Foley catheters. Fifty-one patients were seen and during reflective practice to
find background problems, using Kurt Lewin’s change model theory seen above in
Figure 1. A literature review was conducted to find available knowledge and information
about silver alloy-coated urinary catheters in UTI prevention. Knowledge of use was
gained via database search only; I had not used these catheters or seen them in
practice. Published articles were found using PubMed, Google Scholar, and catheter
manufacturers. The investigation helped show practice gaps and confidence that the
intervention will improve patients’ outcomes and reduce overall costs. This quality
improvement was conducted initially with seven patients; two patients dropped out due
to extraneous issues, and five patients eventually completed it. Patients that took part in
QI consent after the education on catheters.
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Results

Of the five patients that completed the quality improvement intervention with
silver alloy-coated urinary catheters. Two patients’ urinary studies were negative, with
no positive leukocyte esterase, nitrites, or white blood cells in urine. The other two
patients had asymptomatic bacteriuria, colonized bacteria, and multidrug-resistant
organisms. The last patient was symptomatic, another MDRO but positive for yeast. The
last patient was treated with antifungal only

Available Knowledge
Search Strategies
An electronic literature search of PubMed, Google Scholar, Cochrane, SCOPUS,
Embase, and CINAHL were utilized using keywords such as a silver alloy-coated
catheter, asymptomatic bacteriuria, and catheter-related urinary tract infection (CAUTI),
noble catheter, and Foley catheter. Other studies that were prospective, randomized
controlled trials related to the use of the silver alloy catheter in urinary tract infection
prevention were also included in the search that yielded 75 articles. The reliability,
validity, implications to practice, strengths, and weaknesses were examined; all had to
meet the standard for the quality improvement project.
Literature Review
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According to the CDC (2022), CAUTI is defined by a positive urine culture
(bacteriuria) and at least one symptom. Urinary tract infections (UTIs) are the fifth most
common type of healthcare-associated infection, with an estimated 62,700 UTIs in
acute care hospitals in 2015. UTIs additionally account for more than 9.5% of infections
reported by acute care hospitals. Virtually all healthcare associated UTIs are caused by
instrumentation of the urinary tract. (CDC, 2022).
Approximately 12% to 16% of adult hospital inpatients will have an indwelling
urinary catheter (IUC) during their hospitalization. Each day the indwelling urinary
catheter remains, a patient has a 3% to 7% increased risk of getting a catheterassociated urinary tract infection (CAUTI). CAUTI can lead to prostatitis, epididymitis,
orchitis in males, cystitis, pyelonephritis, gram-negative bacteremia, endocarditis,
vertebral osteomyelitis, septic arthritis, endophthalmitis, and meningitis in patients.
Complications associated with CAUTI cause discomfort to the patient and result in a
prolonged hospital stay and increased cost and mortality. It has been estimated that
each year, more than 13,000 deaths are associated with UTIs (CDC, 2022).
According to Sun et al. (2020), urinary tract infections (UTIs) are among the most
common nosocomial diseases, with indwelling catheters contributing to an estimated
80% of these disorders. Catheter-associated UTIs (CAUTIs) can lead to significant
morbidity with prolonged hospital stays and escalation in treatment costs in both highincome and low-income countries. However, nursing personnel are increasingly
involved in preventing hospital-acquired infections and are engaged in daily catheter
care and selecting right catheters to reduce the incidence of CAUTIs. While healthcare
providers often employ standard uncoated catheters, several anti-microbial and anti-
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septic coated catheters are available, reducing the risk of CAUTIs. These catheters are
coated with silver alloy, noble metal alloy, chlorhexidine, and nitrofurazone to minimize
the risk of CAUTIs.
A multicenter randomized, multi-center, prospective clinical study by Kai-Larsen
et al. (2021) showed a significant reduction of CAUTI in patients receiving the NMAcoated BIP Foley catheter versus an uncoated control catheter. A 60% reduction in
bacteriuria translated to a 70% reduction in CAUTI incidence over the whole study
period. The cumulative incidence of CAUTI was significantly lower in the BIP Foley
catheter group between the period three to 30, showing that the device is effective in
both short- and medium-term use. Importantly, this study did not reveal any BIP Foley
catheter safety concerns.
Another study conducted by Chung et al. (2017) reviewed an intervention of a
noble metal coated urinary catheter compared with a standard catheter not coated with
noble metal or any antimicrobial. Thidefinition of the National Healthcare Safety Networ

Rupp et al. (2004) conducted a -year of prospective surveillance study in ten 10
patient care units to find the rate of catheter-associated UTIs. The method used was the
historic control, used to assess the effect of the coated catheter. A cost-effectiveness
analysis was also conducted using a range of cost estimates. Silver susceptibility was
found for microbes responsible for catheter associated UTIs. The study concluded that
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silver alloy, a hydrogel-coated urinary catheter, was associated with a significant decline
in nosocomial UTI and cost savings over cost estimates.
A randomized controlled trial study done by Bonfill et al. (2013) noted the
prevalence of CAUTI in nonacute spinal cord patients who carry indwelling catheters
and increased risks in this population. A comparison was made between standard
urinary catheters and antiseptic silver alloy catheters and found that the latter
intervention proved promising for urinary tract infection (UTI). The trial was a 14-center
randomized trial of 489 patients undergoing spine surgery, with 73% of patients
suffering a traumatic SCI. There was no difference in the median time of catheterization
(27 vs. 28 days; p = 0.202). There was no statistical difference in the rate of CA-UTI in
the experimental 18 patients (18/489 patients; 7.41%) and the control group (19/489;
7.72%) (OR = 0.96). This group also reported an increased rate of adverse events in the
silver alloy-coated catheter. However, the study emphasized that data could not be
extrapolated to spinal cord injury patients.
Benaszek et al. (2020) conducted another study that examined the use of
silver-coated silicone urinary catheters in patients with acute traumatic cervical SCI to
prevent catheter-associated urinary tract infection. Spinal cord injury (SCI) remains one
of the most devastating conditions affecting trauma patients. This study emphasizes
that urinary tract infections are among the most common complications following
traumatic SCI, including pneumonia, neuropathic pain, decubitus ulcers, and delirium.
The Infectious Disease Society of America (IDSA) notes that acceptable guidelines for
catheter use are substantial and symptomatic urinary retention in ineffective medical
therapy, urinary incontinence for terminally ill patients, and correct monitoring of fluid
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status in critically ill patients and during a lengthy surgical procedure. however,
indwelling catheterization of the urinary bladder in SCI patients is an independent risk
factor for UTIs development. Urinary catheters in acute traumatic SCI are initially used
for fluid balance monitoring and prevention of retention in the immediate postoperative
period.. However, an estimated 50% of catheters are placed inappropriately and kept
longer than necessary. The study concluded the efficacy of silver alloy urinary catheters
in decreasing the incidence of CAUTI as well as alterations in the microbiological profile,
hence decreasing antimicrobial sensitivity. Overall, there was a practice due to the
beneficial impact of this study in patients with ATSCI, and a cost-benefit analysis was
performed that showed significant cost savings of noble catheter use and, in the long
run, compared to standard urinary catheters.
Lederer et al. (2014) noted a 47% relative reduction in CAUTI incidence for
silver-alloy hydrogel catheters compared to standard latex catheters. This group
reported 0.945/1000 patient days vs. 0.498/1000 patients’ days in both groups
(and = 0.53; p < 0.0001).
In a multicenter study of CA-UTI rate in ICU patients, Bologna et al., (1999)
noted improved adjusted and unadjusted infection rates for hydrogel/silver-coated
catheters compared to standard latex catheters. The study showed a trend toward a
reduction in NUTIs with the use of the hydrogel/silver-coated catheter was noted in all
intensive care units at each institution as shown by the unadjusted and adjusted
catheter-associated infection rates. One hospital demonstrated a statistically significant
reduction in NUTIs. However, statistical significance was not met when the results were
adjusted. The cost analysis at one institution demonstrated cost savings with the use of

QUALITY IMPROVEMENT PROJECT

14

the silver-coated catheter. Future analysis may require a double-blind, prospectivecontrolled study of longer duration to reach statistical significance.
In a meta-analysis of randomized controlled trials by Saint, et al. (1998), silver
alloy-coated catheters reduced the risk of asymptomatic bacteriuria compared to
standard latex catheters (control latex catheters were either uncoated or coated with
hydrogel, Teflon, or silicone). In contrast, there were no differences compared to
standard silicone catheters.
Another meta-analysis study complied by Saint et al. (2000) assessed the clinical
and economic impact of using silver alloy-coated urinary catheters in hospitalized
patients with silver alloy catheters and standard (noncoated) urinary catheters. The
study concluded with the base-case analysis that the use of silver-coated catheters led
to a 47% relative decrease in the incidence of symptomatic UTI from 30 to 16 cases per
1000 patients (number needed to treat = 74) and a 44% relative decrease in the
incidence of bacteremia from 4.5 to 2.5 cases per 1000 patients (number needed to
treat = 500) compared with standard catheters. The use of silver alloy catheters resulted
in estimated cost savings of $4.09 per patient compared with standard catheter use
($20.87 vs. $16.78). In a multivariate sensitivity analysis using Monte Carlo simulation,
silver-coated catheters supplied clinical benefits over standard catheters in all cases
and cost savings in 84% of cases. Outcomes included the incidence of symptomatic UTI
and bacteremia and direct medical costs.

Karchmer et al. (2000) conducted a 12-month randomized crossover trial that
compared rates of nosocomial catheter-associated UTI in patients with silver-coated
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and uncoated catheters. A cost analysis showed that the risk of infection declined by
21% among study wards randomized to silver-coated catheters and by 32% among
patients in whom silver-coated catheters were used on the controls. The more
expensive silver-coated catheter appeared to save costs by preventing excess hospital
costs from nosocomial UTI associated with catheter use.

Magnusson et al. (2021) conducted a retrospective-prospective clinical case
study to investigate a case of a permanently (suprapubic) catheterized woman with
neurogenic bladder dysfunction. The patient had suffered from recurrent catheterassociated urinary tract infections (CAUTIs) since 2009, despite several prevention
approaches and attempts, such as antibiotic treatments of CAUTI that s gradually
declining as a result rapid development of resistant strains. In 2013, the patient's
catheter was substituted for the BIP Foley Catheter, coated with a noble metal alloy
(NMA) of gold, silver, and palladium. Results showed that long-term use of an NMAcoated catheter was associated with the cessation of frequent CAUTIs. The catheter
experience was reported as comfortable, and inflammatory markers were reduced with
time. The coating was stable, with no significant metal release into the urine, and safe
for the patient. The levels of the noble metal’s gold, silver, and palladium remaining on
the BIP Foley catheter after use were the same as for unused catheters. A catheterassociated urinary tract infection (CAUTI) is almost always preceded by bacteriuria,
developing 3% to 6% per day in catheterized patients. Bacteriuria can be asymptomatic
and may persist as such for extended periods (Magnusson et al., 2021). However, in
many cases, bacteriuria eventually results in local or systemic symptoms, such as
urgency, dysuria, abdominal pain, and fever, and microbes from the urinary tract can
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spread and cause sepsis, septic shock, and multi-organ failure, as reported for 2%,
0.3%, and 1.7% of cases, respectively, got UTIs. As the risk of infection increases with
the duration of catheterization, CAUTI is a significant health burden for patients with
neurogenic bladder dysfunction who use indwelling catheters chronically. These
patients suffer from potentially life-threatening voiding dysfunction owing to a brain,
spinal cord, or other nerve condition caused by, for example, stroke, spinal cord injury
(SCI), multiple sclerosis, or congenital disabilities. CAUTI remains one of the most
prevalent morbidities for these patients, leading to hospitalization with reduced quality of
life.
Comparing these findings to the current quality improvement project, there are
similarities with the development of background problems using the PICOT question,
silver alloy-coated catheters in urinary tract infection prevention, cohort involved,
outcome, and implication to practice. Some studies emphasized no differences in using
both catheters in CAUTI prevention, recommending further studies for clarity. In other
words, the primary outcome of using silver alloy-coated urinary in decreasing the
incidence of CAUTI was achieved.
Specific Aim
This quality improvement aimed to find the efficacy of silver-coated silicone
urinary catheters in preventing CAUTI-associated urinary tract infections in patients with
chronic Foley catheter use with bladder dysfunction. The evaluation processes and
outcomes were evaluated with the QI Model Plan-Do-Study-Act (PDSA) cycle.
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Methods and Design
This quality improvement was conducted in a long-term care facility at The Regal
Estates assisted living for 5 weeks from February 10, 2022, to March 17, 2022. There
were seven patients initially, but two were excluded due to health problems. The
patients, ages 55-99, that agreed with the intervention received the silver alloy-coated
urinary catheters. Patients without chronic catheters, antibiotic therapy, hospice, and
outpatient were excluded from the project. The COVID-19 pandemic had an early
impact on the start date because three patients in the QI project were briefly
hospitalized with COVID-19 pneumonia. Ethical approval was obtained from the
University of Texas at El Paso Institutional Review Board (IRB), which ensures almost
compliance with human subjects. The Regal Estates Assisted Living Facility issued a
letter of support for QI project implementation. Verbal consents were gathered from
patients/POAs that agreed to take part in the project.
The criteria for inclusion in this quality improvement project are patients, 55 to
99 years of age, male and female, with or without traumatic or medical spinal cord
injury. Another inclusion criteria are for patients that will need an indwelling urinary
catheter as a method of bladder drainage for at least 5 weeks. Patients who are willing
to take part in the intervention gave their written informed consent (If a patient is unable
to give written consent because of physical or mental disability, an affirmation of
consent was taken in their presence from their relative or legal guardian). The following
patients were not included in the QI project: Patients who can receive help from another
method of bladder drainages such as intermittent catheterization, or reflex voiding; as
well as those using an external collector. Patients with urinary tract infection on
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antibiotics use or use within 7 days prior to inclusion and patients with Known allergy to
latex, silver salts, or hydrogels. Pregnant or breastfeeding woman.
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Eligibility screening of
patients in an Assisted
living facility
(n-51)

Flow Diagram
Number of patients
that met criteria for
intervention
(n=7)

Number of patients that
dropped due to healthrelated issues
(n=2)

Exclusion criteria- Patients
with bladder problems,
Patients must be residing in
the assisted living facility.

Two patients with a negative
result, two patients with
asymptomatic bacteriuria, one
patient had symptoms but was
only treated for UTI candida

Number of patients with silver
alloy coated catheter that
completed intervention
(n=5)

Inclusion criteria-Patients
on antibiotics, Pregnant
women. Patients without
chronic catheter use
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Intervention and Study
This quality improvement project was developed after a 10-day reflective practice
of fifty-one patients in my clinical practice. Several findings called for intervention, but
the one that stood out more was the high incidence of urinary tract infection and
constant antibiotic treatment, even in situations that were not justified. The impact of this
intervention stems from proven, evidence-based research with the use of silver alloycoated urinary catheters to prevent urinary tract infections. outcome
Patients with chronic indwelling catheters appear to have colonized bacteria.
Clinicians order unnecessary urine studies due to patients, families, and nursing reports
of classic non-UTI symptoms, like agitation, lethargy, and decreased appetite. It is not
valid to completely rule out urinary tract infection in these vulnerable patients, but they
present without any symptoms, hence with asymptomatic bacteriuria. The principal
investigator followed the Standards for Quality Improvement Reporting Excellence 2.0
(SQUIRE) Guidelines during the conduct and reporting process of the quality
improvement project. The outcome measures were shown. This was done by the PlanDo-Study-Act (PDSA) cycle of quality improvement intervention.
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Figure 3
Plan-Do-Study-Act (PDSA) Cycle (Institute for Health Improvement, 2021)

The PDSA Cycle includes three fundamental questions that evaluate the project
aim before change implementation. It must be measurable in its specificity and address
the goal of the proposed intervention. It is essential in finding the feasibility check and
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ensuring benefit to the organization. Before the quality improvement project, the
process of the PDSA cycle involved is as follows:
Plan: Data collection was done after completing a 10-day reflective practice that showed
the frequent diagnosis and treatment of urinary tract infection in a patient with chronic
Foley catheter due to bladder dysfunction. Addressing this issue will improve patient
outcomes and improve costs for the organization. The main goal is to prevent catheterassociated urinary infections using silver alloy-coated urinary catheters.
D0: Quality Improvement Project began on February 10 to March 17, 2022.
The project began and watched for any catheter-associated adverse effects. One
patient’s Foley catheter dislodged required reinsertion, and another had a leakage
requiring replacement.
Study: Results were analyzed and compared. Out of the five patients that took part in
the QI project, two patients’ urine specimens were negative, another two patients’ urine
studies were positive with gram-positive bacteria but remained asymptomatic, and one
was symptomatic.
ACT: The QI project showed a decrease in the use of silver alloy-coated catheters in
preventing CAUTI. There was no antibiotic treatment during the project. The patient was
adequately hydrated. During this stage, changes are noted, refined, and changed if
needed, and in the future, this intervention showed the benefits of cost-saving.
Measures
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The main outcome was the incidence of UTIs by the time of catheter removal or
on the day after catheterization, the event that occurs first. Intention-to-treat analysis
was performed, as well as a primary analysis of all patients. Kurt Lewin’s change model
framework was applied during the project process and the Plan-Do-Study-Act (PDSA)
QI model was used in the translation of theory into practice and were both instrumental
in organizing and examining the scientific theories within the evidenced-based
approach. This quality improvement project was patient-centered, patients were
followed and seen face to face to ensure adherence to the new Foley catheter. The
principal investigator met with the project chair who oversaw and guided the project
process and implementation. Improvement with the silver alloy-coated catheter was
noted with laboratory results documented in the EHR

Analysis
Qualitative data analysis was used to characterize the project population for this
quality improvement project. Fifty-one patients were seen during a 10-day reflective
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practice. Males and females were both included. Other diseases that require
intervention were noted, including Pneumonia, osteomyelitis in diabetic patients, and
total hip and knee repairs due to recurrent falls, but decided to intervene to prevent
catheter-associated urinary tract infection with a special catheter that has been used
according to evidence-based literature in preventing CAUTIs. Five patients were
included in this quality improvement project, data were collected at the end of the
intervention with results illustrated below.

Figure 4
Silver Alloy-Coated Catheter Symptoms in Percentage
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Figure 5
Types of Bacteria Colonization
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Ethical Consideration
All patients that agreed to take part in this quality improvement project willingly
consented. The facility staff was educated on the project’s aim. No payment of any kind
was disbursed to the patients to take part in the project. Patients were solely seen in
their rooms. No form of electronics was used to video or audio tape patients, and there
was no exposure to health risks. Data were collected and stored in the electronic health
record that only the principal investigator used. The facility, Regal Estates assisted
living facility was approved for the QI project prior to implementation. The University of
Texas at El Paso IRB conducted a review to ensure patient protection and all measures
were taken to ensure an ethical QI project.
Results
The quality improvement project was done in a single long-term care facility. The
facility is made up of an executive director, a director of nursing services, and other
nurses (licensed vocational nurses, medication aides, and care staff). There were seven
patients initially, and two were dropped due to medical issues. The remaining five
patients completed the intervention for the duration of 5 weeks, 40% had negative
urinalysis, another 40% were asymptomatic with multidrug-resistant bacteria, and 20%
had no negative urinalysis.
Discussion
Urinary tract infection is one of the most encountered infections in daily clinical
practice, and most cases are catheter-related. Although a few clinical practices such as
an aseptic technique for catheter insertion, closed drainage systems, and a shorter
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duration of catheterization have been introduced to reduce the onset of CAUTI, the
incidence still is high. Therefore, research for strategies or modern technologies to
prevent CAUTI is still needed. Since the early 1990s, research has focused on different
anti-infective catheter-coating materials, but results have been generally inconclusive. A
randomized cross-over study by Karchmer et al.,2000, demonstrated that the risk of UTI
could be decreased by 21% onwards and by 32% among patients when a noble metal
alloy catheter was used instead of a conventional catheter. Since then, more studies to
compare anti-infective urinary catheters with conventional urinary catheters have been
conducted. The noble metal alloy indwelling catheter has been shown in multiple large
clinical trials and smaller case studies to reduce the incidence of CAUTI when
compared with conventional catheters. Bactiguard-coated Foley catheters, an essential
noble metal (gold, silver, and palladium) alloy, and hydrogel-coated catheters have
been introduced to slow bacterial colonization. Additionally, in a study, by Aljohi,
Hassan,& Gupta,(2016) the CAUTI-reducing efficacy of silver alloy-coated catheters
was evaluated in the Intensive Care Unit (ICU) at the King Fahad Hospital in Saudi
Arabia. Results showed the efficacy of silver alloy-coated urinary catheter use and
demonstrate a 90% (P = 0.006) relative reduction in the silver alloy-coated catheter
group of the CAUTI rate.
Implications and Limitations

The use of a silver alloy-coated urinary catheter potentially reduces the incidence
of CAUTI. This will lead to less morbidity and medical costs associated with CAUTI.
This quality improvement project was relatively short, 5 weeks, and only done with five
patients in a small facility.
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Conclusion
The result of this quality improvement project supports the routine use of silvercoated indwelling urinary catheters in patients with bladder dysfunction. One important
risk factor for CAUTI and bacteriuria is the duration of catheterization. While it is
hypothesized that noble metal coating may reduce the biofilm formation, no material has
been found to date that cuts bacterial colonization and biofilm formation; and bacteriuria
may only be delayed with such a catheter. Given the morbidity and costs associated
with catheter related UTIs, preventive measures have been tried, including the addition
of silver coating to urinary catheters.
This QI project type is very significant to nursing practice because they offer the
Doctor of Nursing Parctice (DNP) prepared advanced practice registered nurse (APRN)
the opportunity to indulge in evidenced-based research, synthesis, critique robust
literature reviews, and translate theories and findings into clinical practice. It affords the
DNP student the opportunity to practice within the scope of the student’s education.
Finally, the QI intervention’s goal is to improve patient care and outcomes and at the
long run save costs. Completing and applying these findings in practice is rewarding for
the doctoral-prepared advanced practice nurse. This will ensure that the APRN is well
equipped with skills to find gaps in care, contribute to change in healthcare, and
improve healthcare delivery.
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